Table 1.
Characteristics of Jackson Heart Study participants by category of 10-year predicted atherosclerotic cardiovascular risk.
| 10-year predicted ASCVD risk | |||||
|---|---|---|---|---|---|
| Characteristics | <5% | ≥5% to <7.5% | ≥7.5% to <10% | ≥10% | p-trend |
| (n=212) | (n=93) | (n=74) | (n=265) | ||
| Age, years | 49.6 ± 6.1 | 57.8 ± 6.7 | 61.8 ± 6.4 | 66.2 ± 6.8 | <0.001 |
| Male, % | 14.2 | 33.3 | 33.8 | 40.4 | <0.001 |
| Less than high school education, % | 6.2 | 19.4 | 16.2 | 21.7 | <0.001 |
| Current smoking, % | 5.7 | 7.5 | 5.4 | 10.9 | 0.045 |
| Diabetes, % | 1.9 | 6.5 | 13.5 | 40.4 | <0.001 |
| eGFR <60 ml/min/m2, % | 0.0 | 5.4 | 10.8 | 14.7 | <0.001 |
| Body mass index, kg/m2 | 31.1 ± 7.6 | 31.7 ± 6.1 | 31.3 ± 6.6 | 30.6 ± 5.2 | 0.261 |
| Total cholesterol, mg/dL | 196.9 ± 35.5 | 199.9 ± 36.3 | 202.3 ± 36.6 | 208.7 ± 42.9 | <0.001 |
| LDL cholesterol, mg/dL | 121.9 ± 35.0 | 125.5 ± 36.4 | 126.8 ± 35.4 | 131.1 ± 36.4 | 0.005 |
| HDL cholesterol, mg/dL | 56.7 ± 15.1 | 52.9 ± 14.4 | 54.2 ± 12.4 | 54.4 ± 15.0 | 0.135 |
| Antihypertensive medication use, % | 25.0 | 51.6 | 59.5 | 73.2 | <0.001 |
The numbers in the table are mean ± standard deviation or percentages.
ASCVD: Atherosclerotic cardiovascular disease
eGFR: estimated glomerular filtration rate
HDL: high-density lipoprotein
LDL: low-density lipoprotein